76008-75-8Relevant articles and documents
A convergent strategy towards febrifugine and related compounds
Maiden,Mbelesi,Procopiou,Swanson,Harrity
, p. 4159 - 4169 (2018/06/12)
We report a modular five step synthetic route to the febrifugines that employs 2-(chloromethyl)allyl-trimethylsilane as a conjunctive reagent for the coupling of the piperidine and quinazolinone groups. We also demonstrate the application of a recent Rh-catalyzed quinazolinone synthesis for the facile generation of febrifugine analogs.
INDAZOLE DERIVATIVES THAT INHIBIT TRPV1 AND USES THEREOF
-
Page/Page column 34, (2008/06/13)
Compounds of formula (I) wherein R3, R7, R9 and L are defined in the description are TRPV1 antagonists that exhibit low inhibitory activity against CYP3A4. Compositions comprising such compounds and methods for treating co
Heterocyclic derivatives for the treatment of diabetes and other diseases
-
, (2008/06/13)
The present invention relates to certain substituted heterocycles of Formula (I) which are useful in the treatment of diseases related to lipid and carbohydrate metabolism, such as type 2 diabetes, adipocyte differentiation, uncontrolled proliferation, such as lymphoma, Hodgkin's Disease, leukemia, breast cancer, prostate cancer or cancers in general; and inflammation, such as osteoarthritis, rheumatoid arthritis, Crohn's Disease or Inflammatory Bowel Disease.